Prenatal HIV Screening in Pregnant Women: A Medical-Legal Review

Birth

Volumn 24, Issue 3, 1997, Pages 165-172

  Oldenettel, Debra ^a   Dye, Timothy D ^a   Artal, Raul ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; COST; DISEASE TRANSMISSION; ECONOMICS; FEMALE; HEALTH CARE AND PUBLIC HEALTH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JURISPRUDENCE; PREGNANCY; PREGNANCY COMPLICATION; PREGNANT WOMAN; PRENATAL CARE; REVIEW; RISK ASSESSMENT; SERODIAGNOSIS; UNITED STATES; VOLUNTARY PROGRAM; VULNERABLE POPULATION;

HEALTH CARE AND PUBLIC HEALTH;

ADULT; AIDS SERODIAGNOSIS; COSTS AND COST ANALYSIS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; JURISPRUDENCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANT WOMEN; PRENATAL CARE; RISK ASSESSMENT; UNITED STATES; VOLUNTARY PROGRAMS; VULNERABLE POPULATIONS;

EID: 0031228542     PISSN: 07307659     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-536x.1997.tb00581.x     Document Type: Review

References (46)

1. Fehrs LJ, Hill D, Kerndt PR, et al. Targeted HIV screening at a Los Angeles prenatal/family planning health center. Am J Public Health 1991;81(5):619-622.
2. Barbacci M, Repke JT, Chaisson RE. Routine prenatal screening for HIV infection. Lancet 1991;337:709-711.
3. Crawford C. Protecting the weakest link: A proposal for universal unblinded pediatric HIV testing, counseling and treatment. J Community Health 1995;20(2):125-141.
4. Centers for Disease Control and Prevention AIDS rates - United States. Morbid Mortal Weekly Rep 1996;45(42):926-927.
5. Centers for Disease Control and Prevention. AIDS among children - United States. Morbid Mortal Weekly Rep 1996;45(46):1005-1010.
6. Maldonado YA, Wang NE, Calwell B. Factors associated with early clinical recognition of children with perinatal human immunodeficiency virus infection. J Infect Dis 1995;171 (March):689-692.
7. Modlin J, Saah A. Public health and clinical aspects of HIV infection and disease in women and children in the United States. In: Faden RR, Geller G, Powers M, eds. AIDS, Women and the Next Generation. New York: Oxford University Press, 1991:29-58.
8. Hardy LM, ed. HIV Screening of Pregnant Women and Newborns. Washington D.C.: National Academy Press, 1991.
9. Husson RN, Comeau AM, Hoff R. Diagnosis of human immunodeficiency virus infection in infants and children. Pediatrics 1990;86(1):1-10.
10. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. Atlanta: Author, 1990.
11. United States Congress, House. H.R. 4507. 103d Congress, 2d Session. May 26, 1994.
12. New York State Department of Health. Maternal - Pediatric HIV Prevention and Care Program: HIV Counseling and Voluntary Testing of Pregnant Women: Routine HIV Testing of Newborns as Part of the Comprehensive Newborn Testing Program. Series 97-2. Albany: Author, 1997.
13. Curnin KJ. Newborn HIV screening and New York Assembly Bill no. 6747-B: Privacy and equal protection of pregnant women. Fordham Urban Law 1994;XXI:857-926.
14. Walters L. Ethical issues in HIV testing during pregnancy. In: Faden RR, Geller G, Powers M, eds. AIDS, Women and the Next Generation. New York: Oxford University Press, 1991:274-287.
15. Acuff K, Faden R. A history of prenatal and newborn screening programs: Lessons for the future. In: Faden RR, Geller G, Powers M, eds. AIDS, Women and the Next Generation. New York: Oxford University Press, 1991:59-93.
16. Wilfert CM. Beginning to make progress against HIV. N Engl J Med 1996;335:1678-1680.
17. Centers for Disease Control and Prevention. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. Morbid Mortal Weekly Rep 1995;44(RR-7):1-16.
18. Conner EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331(18):1173-1180.
19. American College of Obstetricians and Gynecologists. Committee on Obstetric Practice. Zidovudine for the Prevention of Vertical Transmission of Human Immunodeficiency Virus. ACOG Committee Opinion 148. Washington, D.C.: Author, 1994.
20. Selwyn PA, Carter RJ, Shoenbaum EE, et al. Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA 1989;261:3567-3571.
21. Johnstone FD, Brettle RP, MacCallum R, et al. Women's knowledge of their HIV antibody state: Its effect on their decision whether to continue the pregnancy. BMJ 1990;300:23-24.
22. Voss, DH. Perinatal AIDS. OB/GYN On Call 1995;4(1):2-4.
23. Bayer R. Ethical challenges posed by zidovudine treatment to reduce vertical transmission of HIV. N Engl J Med 1994;331:1223-1225.
24. Holman S, Sunderland M, Berthaud G, et al. Prenatal HIV counseling and testing. Clin Obstet Gynecol 1989;32:445-455.
25. Holtgrave DR, Qualls NL, Curran JW, et al. An overview of the effectiveness and efficiency of HIV prevention programs. Public Health Rep 1995;110:134-146.
26. Higgins DL, Galavotti C, O'Reilly KR, et al. Evidence for the effects of HIV antibody counseling and testing on risk behaviors. JAMA 1991;266:2419-2429.
27. Ickovics JR, Morrill AC, Beren SE, et al. Limited effects of HIV counseling and testing for women. JAMA 1994;272:443-448.
28. Aranda-Naranjo B. AIDS clinical trial group (076). J Assoc Nurses AIDS Care 1995;6(3):43-44.
29. Hsia DC, Welshman JA, East JA, Hellinger FJ. Pediatric human immunodeficiency virus infection: Recent evidence on the utilization and costs of health services. Arch Pediatr Adolesc Med 1995;149(5):489-497.
30. Gorsky RD, Farnhum PG, Straus WL, et al. Preventing perinatal transmission of HIV - costs and effectiveness of a recommended intervention. Public Health Rep 1996;111:335-341.
31. Mauskopf JA, Paul JE, Wichman DS, et al. Economic impact of treatment of HIV-positive women and their newborns with zidovudine: Implications for HIV screening. JAMA 1996;276:132-138.
32. Faden RR, Geller G, Powers M, editors. AIDS, Women and the Next Generation. New York: Oxford University Press, 1991.
33. Allen AL. Legal issues in nonvoluntary prenatal HIV screening. In: Faden RR, Geller G, Powers M, eds. AIDS, Women and the Next Generation. New York: Oxford University Press, 1991:166-200.
34. Glover v Eastern Nebraska Community Office of Retardation, 867 F.2d 461 (8th Cir. 1989).
35. Griswold v Connecticut, 381 U.S. 479 (1965).
36. Roe v Wade, 410 U.S. 113 (1973).
37. Webster v Reproductive Health Services, 109 S. Ct. 3040 (1989), reversing 851 F.2d 1071 (8th Cir. 1988).
38. Gwinn M, Pappaioanou M, George JR, et al. Prevalence of HIV infection in childbearing women in the United States: Surveillance using newborn blood samples. JAMA 1991;265(13):1704-1708.
39. Hinman AR. What will it take to fully protect all American children with vaccines? Am J Dis Child 1991;145:559-562.
40. Wilfert CM. Mandatory screening of pregnant women for the human immunodeficiency virus. Clin Infect Dis 1994;19:664-666.
41. Coplan J, Dye TD, Contello K, et al. Failure to identify human immunodeficiency virus-seropositive newborns: Epidemiology and enrollment patterns in a predominantly white, nonurban setting. Pediatrics 1995;96(6):1-7.
42. Fiscus SA, Adimora AA, Schoenbach VJ, et al. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties. JAMA 1996;275:1483-1488.
43. Lindsay MK, Peterson HB, Feng TI, et al. Routine antepartum human immunodeficiency virus infection screening in an inner-city population. Obstet Gynecol 1989;74(3):289-294.
44. Cooper ER, Nugent RP, Diaz C, et al. After AIDS clinical trial 076: The changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. J Infect Dis 1996;174:1207-1211.
45. American Academy of Pediatrics. Perinatal human immunodeficiency virus testing. Pediatrics 1995;95(2):303-307.
46. Minkoff H, Willoughby A. Pediatric HIV disease, zidovudine in pregnancy, and unblinding heelstick surveys (commentary). JAMA 1995;274:1165-1168.